HER2 Archives - AudioMedica.com

Tagged: HER2

in Oncology · Video
— 19 Nov, 2013

The TH3RESA study: TDM-1 doubles progression free survival in HER-2 positive refractory metastatic breast cancer.

AMSTERDAM—Women with HER-2 positive metastatic breast cancer had significantly improved time to progression with fewer side effects after treatment with the antibody-drug conjugate T-DM1 compared to conventional therapies in the phase three TH3RESA study presented to the 2013 European Cancer …

in ASCO · Oncology
— 16 Feb, 2007

ASCO Audio Journal of Oncology in Advance – February 15th, 2007 – reporting from San Antonio Breast Cancer Symposium, December 13-17, 2007

Rachel Johnson

Terry Mamounas

William Gradishar

Withhold Trastuzumab in Low-Risk Patients with HER-2 Positive Breast Cancer?

REFERENCE: Abstract: 2090
RACHEL JOHNSON, Christie Hospital, Manchester
Some patients with HER-2 positive early breast cancer fare better if trastuzumab is withheld, according to

…

- in AJO · Oncology
- — 17 Jan, 2007
Audio Journal of Oncology in Advance – January 15th, 2007 – HERA Study Results Confirm Trastuzumab Benefit in HER2 Positive Early Breast Cancer
IAN SMITH, Royal Marsden Hospital, London
REFERENCE: Lancet 369:29
Confirmation of the life-extending benefits of trastuzumab adjuvant therapy for early breast cancer has been published recently in the Lancet. Ian Smith gave Peter Goodwin three-year follow up results from
…
More

Tagged: HER2

The TH3RESA study: TDM-1 doubles progression free survival in HER-2 positive refractory metastatic breast cancer.

ASCO Audio Journal of Oncology in Advance – February 15th, 2007 – reporting from San Antonio Breast Cancer Symposium, December 13-17, 2007

Withhold Trastuzumab in Low-Risk Patients with HER-2 Positive Breast Cancer?

Audio Journal of Oncology in Advance – January 15th, 2007 – HERA Study Results Confirm Trastuzumab Benefit in HER2 Positive Early Breast Cancer

Sign up for AudioMedica.com news